WHO ICTRP trial
Study to Compare the Efficacy and Safety of Single Dose Dalbavancin to a Two…
EUCTR2014-000419-15-LV · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2014-000419-15-LV |
|---|---|
| Public title | Study to Compare the Efficacy and Safety of Single Dose Dalbavancin to a Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections |
| Scientific title | A Phase 3b, Double-Blind, Multicenter, Randomized Study to Compare the Efficacy and Safety of Single Dose Dalbavancin to a Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections |
| Primary sponsor | Durata Therapeutics International B.V. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Serbia;United States;Hungary;Estonia;Ukraine;Romania;Croatia;Russian Federation;Georgia;Bulgaria;South Africa;Latvia |
| Conditions | Acute Bacterial Skin and Skin Structure Infections MedDRA version: 17.1 Level: PT Classification code 10052891 Term: Skin bacterial infection System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Skin… |
| Interventions | Trade Name: Dalvance Product Name: Dalbavancin Product Code: DUR001 Pharmaceutical Form: Powder for concentrate for solution for infusion INN or Proposed INN: DALBAVANCIN CAS Number: 171500-79-1 Current Sponsor code: DUR001 Concentration… |
| Registration date | Apr 7, 2014 |
| Target size | 698 |
| Secondary IDs | DUR001-303;60,613 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: